Prism Medico and Pharmacy Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 1.45 million compared to INR 12.71 million a year ago. Revenue was INR 2.4 million compared to INR 12.72 million a year ago. Net loss was INR 0.676 million compared to net income of INR 0.507 million a year ago. Basic loss per share from continuing operations was INR 0.0011 compared to basic earnings per share from continuing operations of INR 0.0008 a year ago. Diluted loss per share from continuing operations was INR 0.0011 compared to diluted earnings per share from continuing operations of INR 0.0008 a year ago.
For the full year, sales was INR 29.25 million compared to INR 12.71 million a year ago. Revenue was INR 30.48 million compared to INR 12.72 million a year ago. Net loss was INR 0.214 million compared to INR 0.763 million a year ago. Basic loss per share from continuing operations was INR 0.05 compared to INR 0.13 a year ago. Diluted loss per share from continuing operations was INR 0.05 compared to INR 0.13 a year ago. Basic loss per share was INR 0.05 compared to INR 0.13 a year ago. Diluted loss per share was INR 0.05 compared to INR 0.13 a year ago.